Rebecca Klee

Mrs. Rebecca Klee

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
KTKristen Thane
Kristen Thane
RVRebecca Voth
Rebecca Voth
RKRebecca Klee
Rebecca Klee
TWTobias Warnken
Tobias Warnken
VCVictor Chukwu
Victor Chukwu
NFNicholas Frank
Nicholas Frank
Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are promising treatments to manage hyperinsulinemia in horses with insulin dysregulation (ID). Hypothesis: The SGLT2i velagliflozin decreases insulin concentration in horses with ID. Animals: Privately-owned adult horses (n = 37) with laboratory-confirmed ID (low-dose oral sugar test insulin concentration > 75 μIU/mL). Methods: Double-blind randomized placebo-controlled trial. Horses received placebo (n = 19) or velagliflozin 0.3 mg/kg PO q24h (n = 18) for 20 weeks (Study Period 1, SP1) immediately followed by a 20-week open-label trial where all animals received velagliflozin (SP2). Analysis of resting insulin, glucose, and triglyceride concentrations and body condition score (BCS) was performed between treatment groups and study periods using a Mann–Whitney U test. For SP1, analysis of changes in biochemical analytes over time was performed using generalized linear mixed effects models (GLMM). Data are reported as median (interquartile range). Results: In SP1, GLMM indicated a significant effect of treatment on insulin concentration (71 [33–131] μIU/mL in horses receiving velagliflozin and 157 [82–298] μIU/mL in horses receiving placebo; p < 0.0001). The average (95% confidence interval [CI]) effect of velagliflozin treatment on insulin concentration was 155 (90–219) μIU/mL. Horses receiving placebo in SP1 had lower insulin (50 [26–99] μIU/mL) during SP2 (p < 0.0001). All horses experienced a transient increase in serum triglyceride concentration during velagliflozin treatment with no clinical abnormalities reported. In SP1, larger decreases in BCS occurred in horses receiving velagliflozin (median BCS 1 point lower than baseline; p = 0.02) than those receiving placebo. Conclusions: Velagliflozin significantly decreased resting insulin concentrations in horses with ID.

7 January 2021 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
AMA. Meier
A. Meier
JMJames McGree
James McGree
RKRebecca Klee
Rebecca Klee
JPJ. Preuß
J. Preuß
DRD. Reiche
D. Reiche
MSMartin N. Nicholas Sillence
Martin N. Nicholas Sillence
Background: Endocrinopathic, or hyperinsulinaemia-associated laminitis (HAL) is a common and debilitating equine foot disease, and although no pharmacological treatments are registered, several are under development. To evaluate the effect of such treatments, an accurate and consistent method is needed to track the clinical signs of laminitis over time, and the natural history of the disease, in terms of a ‘normal’ pattern of improvement, needs to be understood. This study examined the improvement pattern in clinical cases of naturally-occurring HAL subjected to a range of best-practice interventions, using two different scoring methods. Eighty horses and ponies with suspected HAL were enrolled in a study conducted at 16 veterinary practices across Germany. The severity of laminitis was assessed by independent veterinarians using both the traditional Obel method and a modified Obel method developed by Meier and colleagues. Assessments were made on the day of diagnosis (d 0), then on days 4, 9, 14, 25 and 42 during the intervention period. Pain medications were withheld for 24 h prior to clinical examination in all cases.Results: Time to marked improvement from laminitis varied between individuals, but was difficult to monitor accurately using the Obel method, with the median grade being 2/4 on days 0 and 4, then 0/4 from d 9 onwards. More subtle changes could be identified using the Meier method, however, and the median scores were seen to follow the form of an exponential decay model in most horses, improving from 8/12 on d 0, to 0/12 on d 25. Within this composite scoring method, considerable variation was observed in the rate of improvement of individual clinical signs, with the average time taken for each sign to reach a median score of 0 ranging from 4 days (foot lift and weight shifting) to 25 days (gait when turned in a circle) across all 80 horses.Conclusions: The Meier method provides a reliable and consistent method for monitoring the clinical status of horses with HAL, and despite the variability, the pattern of improvement described here should provide a useful benchmark against which individual cases and new treatments can be assessed.

18 January 2022 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
MSMartin N. Nicholas Sillence
Martin N. Nicholas Sillence
AMAlexandra Meier
Alexandra Meier
MLMelody de Laat
Melody de Laat
RKRebecca Klee
Rebecca Klee
DRDania Reiche
Dania Reiche
Although several studies have investigated factors associated with the onset and occurrence of hyperinsulinaemia-associated laminitis (HAL), few have examined the factors associated with the rate of improvement during recovery from an acute bout of the disease. This observational study sought to discover if a range of demographic, morphologic, hormonal and metabolic variables are associated with the improvement rate from HAL in 37 naturally-occurring cases identified by 16 clinics across Germany. Each case was evaluated for laminitis severity on the day of inclusion in the trial (d 0), then after 4, 9, 14, 25 and 42 d. The horses were managed according to best clinical practice including restricting exercise and prescribing a diet of hay-only, for a minimum of 9 d. Blood samples were also collected during each evaluation, except on d 9, and analysed for glucose, insulin, ACTH and leptin. Based on individual clinical laminitis scores plotted against time, most horses improved markedly within 2 weeks, with a ‘fast group’ (n = 27) having a median (interquartile range) score on a 12-point scale of 0 (0–2) by d 14. However, there was a clear disparity within the total cohort, as ~ 1 in 4 horses demonstrated much slower improvement, with a median score of 5 (4–7) by d 14, or a marked relapse thereafter (‘slow group’, n = 10). Horses in the slow improvement group were younger (12.5 (8.8–16.3) vs 17 (14–24) yr; P = 0.008), but were not more likely to be heavier, male, very fat, to have presented with a previous history of laminitis or elevated ACTH concentrations, or to be receiving pergolide treatment. Of the hormonal and metabolic parameters measured, glucose and insulin concentrations were within the normal range following transition to the hay-only diet, but were higher in the group that failed to improve quickly, with a small but significant difference being evident on d 4, 14 and 25 for glucose (11 to 16%; P < 0.05), and a larger difference for insulin on d 14 and 25 (51 to 55%; P < 0.05). There was no difference between the groups in ACTH or leptin concentrations throughout the study. The main limitations of this study were the small number of slow-improvement horses and an inability to control or measure certain variables, such as feed quality. Young age and a modest increase in blood glucose and insulin concentrations are associated with delayed laminitis improvement.

17 June 2025 in Animals
Verified
Journal Article
Open access
PDF file
Friederike Felicitas RheinFriederike Felicitas Rhein
Friederike Felicitas Rhein
RKRebecca Klee
Rebecca Klee
BABalazs Albrecht
Balazs Albrecht
Stephanie KrämerStephanie Krämer
Stephanie Krämer
Quality of life (QoL) assessment has increased in veterinary medicine in recent years, as has the number of attempts to measure it. This review aimed to provide an overview and assess the quality of existing instruments measuring disease-specific QoL in dogs. The PubMed and CAB Abstracts databases were searched in February 2023 using search terms associated with dogs, well-being, and QoL to identify relevant articles which were then evaluated for information on the development and validation processes. For further analysis, 41 publications were selected, of which instruments were available for 30 publications; of these, 24 contained information on item development, while 12 of the 41 instruments described some form of instrument evaluation. Among these 12 instruments, 2 exhibited appropriate test–retest reliability, 7 exhibited acceptable internal consistency, 9 checked at least one face or content validity, and 8 tested at least one sort of hypothesis to contribute to construct validity evaluation. None of the instruments were thoroughly evaluated for all necessary psychometric aspects for their application and result interpretation. Therefore, these instruments’ usage should be carefully considered and subject to restrictions. Further research should focus on establishing guidelines aiming to achieve high standards for instrument development and validation in veterinary medicine.

16 December 2025 in Animals
Verified
Journal Article
Open access
PDF file
Friederike Felicitas RheinFriederike Felicitas Rhein
Friederike Felicitas Rhein
RKRebecca Klee
Rebecca Klee
BABalazs Albrecht
Balazs Albrecht
Stephanie KrämerStephanie Krämer
Stephanie Krämer
The assessment of animal welfare and quality of life (QoL) is a critical aspect of veterinary practice. While the development of standardized tools to measure QoL has been widely discussed, there is limited research analyzing how these tools are applied in clinical practice. This study investigates the current state of QoL assessment in small animal medicine in Germany through a mixed-methods approach. A survey was conducted with veterinarians and veterinary assistants, assessing the awareness and use of QoL assessment tools in practice. In addition, interviews with veterinarians were conducted to examine their perceptions and experiences regarding the use of QoL measurement tools and the assessment of QoL itself. The findings indicate that the use of standardized QoL assessments is rare and often primarily done while doing studies. Factors hindering the widespread use of these instruments include lack of time, lack of awareness, the perceived lack of need and resistance to fitting the individuality and subjectivity of QoL into a schema. As beneficial features of such tools, veterinarians mentioned the possibility of documenting and tracking QoL and the enhancement of the relationship between professionals and clients. Further research should therefore not only focus on development but also on dissemination of such tools.